[
  {
    "ts": "2025-12-04T04:01:56+00:00",
    "headline": "3 Reasons WST is Risky and 1 Stock to Buy Instead",
    "summary": "West Pharmaceutical Services’s 34.6% return over the past six months has outpaced the S&P 500 by 20.2%, and its stock price has climbed to $284.57 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
    "url": "https://finance.yahoo.com/news/3-reasons-wst-risky-1-040156818.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "5cb2588c-3a0d-3d8d-9e2b-3037f5604f03",
      "content": {
        "id": "5cb2588c-3a0d-3d8d-9e2b-3037f5604f03",
        "contentType": "STORY",
        "title": "3 Reasons WST is Risky and 1 Stock to Buy Instead",
        "description": "",
        "summary": "West Pharmaceutical Services’s 34.6% return over the past six months has outpaced the S&P 500 by 20.2%, and its stock price has climbed to $284.57 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
        "pubDate": "2025-12-04T04:01:56Z",
        "displayTime": "2025-12-04T04:01:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/0a7131c3c60abde7f623f12aa0840d12",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "WST Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sSo4Y0O6fK3srLaBp2GOtw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/0a7131c3c60abde7f623f12aa0840d12.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/65j8gZhdqmvJSKJWauAyCA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/0a7131c3c60abde7f623f12aa0840d12.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-wst-risky-1-040156818.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-wst-risky-1-040156818.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T13:45:24+00:00",
    "headline": "West Pharmaceutical Services (WST) Rebounded in Q3",
    "summary": "Brown Advisory, an investment management company, released its “Brown Advisory Large-Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned -0.88% (net) during the third quarter, underperforming the benchmark, the Russell 1000 Growth Index. Even though the portfolio has significant exposure to AI, its underweight to […]",
    "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-rebounded-134524038.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "2ecff6e8-f092-3519-b55d-addb6833d6db",
      "content": {
        "id": "2ecff6e8-f092-3519-b55d-addb6833d6db",
        "contentType": "STORY",
        "title": "West Pharmaceutical Services (WST) Rebounded in Q3",
        "description": "",
        "summary": "Brown Advisory, an investment management company, released its “Brown Advisory Large-Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned -0.88% (net) during the third quarter, underperforming the benchmark, the Russell 1000 Growth Index. Even though the portfolio has significant exposure to AI, its underweight to […]",
        "pubDate": "2025-12-04T13:45:24Z",
        "displayTime": "2025-12-04T13:45:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/3da65c788695754bfdb5c982fc3e065c",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "TD Cowen Initiates Coverage on West Pharmaceutical (WST) with Buy Rating and $350 Target",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PGr9HSGyEBZ0qk1Tzaju6w--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3da65c788695754bfdb5c982fc3e065c.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OUOi2LvoJ_pBGZws_4e16A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3da65c788695754bfdb5c982fc3e065c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-rebounded-134524038.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-rebounded-134524038.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]